LUTALYSE (dinoprost tromethamine) Sterile Solution was one of the first natural estrus-synchronization products approved for swine more than 20 years ago, and it remains unsurpassed today. It gives producers more live pigs as the result of greater production efficiencies at and after farrowing. LUTALYSE is indicated for parturition induction in gilts and sows.
Cattle IMPORTANT SAFETY INFORMATION: Women of childbearing age and persons with respiratory problems should exercise extreme caution when handling LUTALYSE. LUTALYSE is readily absorbed through the skin and may cause abortion and/or bronchiospasms, therefore spillage on the skin should be washed off immediately with soap and water. Aseptic technique should be used to reduce the possibility of post-injection clostridial infections. Do not administer LUTALYSE in pregnant cattle unless cessation of pregnancy is desired. See full Prescribing Information, attached.
Equine IMPORTANT SAFETY INFORMATION: Women of childbearing age and persons with respiratory problems should exercise extreme caution when handling LUTALYSE. LUTALYSE is readily absorbed through the skin and may cause abortion and/or bronchiospasms, therefore spillage on the skin should be washed off immediately with soap and water. Pregnancy status should be determined prior to treatment, as abortion and parturition have been reported. Aseptic technique should be used to reduce the possibility of post-injection clostridial infections. Do not use in horses intended for human consumption. See full Prescribing Information, attached.
Swine IMPORTANT SAFETY INFORMATION: Women of childbearing age and persons with respiratory problems should exercise extreme caution when handling LUTALYSE. LUTALYSE is readily absorbed through the skin and may cause abortion and/or bronchiospasms, therefore spillage on the skin should be washed off immediately with soap and water. Aseptic technique should be used to reduce the possibility of post-injection clostridial infections. Do not administer to sows or gilts prior to 3 days of normal predicted farrowing, as an increased number of stillbirths and postnatal mortality may result.
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
For animals. For health. For you.
This site is intended for U.S. Animal Healthcare Professionals.
Product Information
United States 
